United States · Investor

BlueTree Allied Angels

Last cheque observed Jun 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietAngel network

Series BSeries ASeedEducationTrainingInvestment Management

Cheques on record
0%of best year0cheques in 12 months, 15 on record
Since the last cheque2692days00hrs00min00sec
Median round$7.0MRounds led0 of 15Sole investor1 roundsMostly inUnited States, 100%
Pitch BlueTree Allied Angels

BlueTree Allied Angels highlights

  1. 01

    15 rounds on record

  2. 02

    Mostly Series B and Series A: 71% of its rounds

  3. 03

    Sole investor in 1 rounds, median undisclosed

What they do

Type
Angel network (from a list, unverified)
Cheque size
Not stated
Sectors
EducationTrainingInvestment Management
Based in
Pittsburgh, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first15 appearances

  1. 2019

    1 round

  2. Jun
    Edge Case ResearchUS · Globenewswire$7.0MWith 5 others
  3. 2015

    1 round

  4. Apr
    PittMossSeedUndisclosedWith 1 other
  5. 2014

    6 rounds

  6. Dec
    Rinovum Women's HealthSeries C · US$3.0MWith 1 other
  7. Jul
    Wombat Security TechnologiesSeries B · US$6.7MWith 2 others
  8. Jun
    Carmell TherapeuticsSeries A · US$1.0MWith 3 others
  9. May
    Gemmus PharmaSeries B · US$3.3MWith 4 others
  10. Apr
    Cognition TherapeuticsSeries B · US$6.0MWith 1 other
  11. Apr
    Neuros MedicalSeries B · US$4.0MWith 2 others
  12. 2013

    2 rounds

  13. Sept
    ALung TechnologiesSeries B · US · finsmes.com$16MWith 8 others
  14. Aug
    PhyscientSeries A · US · sec.gov$869KWith 2 others
  15. 2012

    1 round

  16. Jun
    Gemmus PharmaSeries A · US · sec.gov$1.8MWith 4 others
  17. 2011

    1 round

  18. Apr
    Carmell TherapeuticsSeries A · US · bizjournals.com$2.4MWith 5 others
  19. 2008

    2 rounds

  20. Sept
    DiaKine TherapeuticsSeedUndisclosedSole investor
  21. Jun
    TalkShoeSeed · US$1.1MWith 4 others
  22. 2007

    1 round

  23. Apr
    StageMarkSeries B · US · allbusiness.com$1.6MWith 6 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Who they invest alongside

The investors most often in the same rounds as BlueTree Allied Angels. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies BlueTree Allied Angels put money into.

Quick answers about BlueTree Allied Angels

What does BlueTree Allied Angels invest in?

BlueTree Allied Angels invests most often at Series B and Series A (71% of the rounds on record), in sectors such as Education, Training and Investment Management.

How active is BlueTree Allied Angels?

15 investments on record, 0 of them in the last 12 months. The most recent was in Jun 2019.

What has BlueTree Allied Angels invested in recently?

Its most recent investments on record: Edge Case Research (Undisclosed round, Jun 2019).

How big are BlueTree Allied Angels's cheques?

The median round it joins is $7.0M.

Does BlueTree Allied Angels lead rounds?

Rarely, if at all: none of its 15 investments on record names it as the lead.

Where does BlueTree Allied Angels invest?

Most of the companies it backs are in the United States (100%).

Is BlueTree Allied Angels investing now?

No investments in the last 12 months; the latest was in Jun 2019.

Who does BlueTree Allied Angels invest alongside?

Most often Innovation Works (5 rounds together), Pittsburgh Life Sciences Greenho (4 rounds together) and Life Science Angels (3 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it